Northera 100 MG capsule 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FKKH0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,643
Award facts
- Contract value 100% obligated
- $5,642.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 90 Northera 100 mg capsules valued at $5,642.50. The delivery order, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, carries no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.99 billion master contract awarded on November 13, 2025, that positions the company as a critical regional pharmaceutical supplier for Department of Defense healthcare operations.
The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to support the recurring pharmaceutical and medical consumables needs of military healthcare facilities worldwide. Under this framework, DMS Pharmaceutical Group is authorized to supply an extensive portfolio including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The company's demonstrated performance across numerous delivery orders spanning multiple therapeutic categories has established it as a reliable supplier within the federal pharmaceutical supply chain, with the current delivery order for Northera exemplifying the routine procurement activity supporting Department of Defense medical operations.
Quick answers
Who was awarded contract SPE2DR26FKKH0?
SPE2DR26FKKH0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FKKH0 worth?
The government has obligated $5,643 on SPE2DR26FKKH0.
Is contract SPE2DR26FKKH0 an order under another contract?
Yes. SPE2DR26FKKH0 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKH0 competed?
The extent of competition for SPE2DR26FKKH0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award